BlackRock Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$341K Buy
5,576
+226
+4% +$14.7K ﹤0.01% 2437
2016
Q3
$370K Sell
5,350
-38,664
-88% -$2.55M ﹤0.01% 2331
2016
Q2
$2.45M Buy
44,014
+15,964
+57% +$963K ﹤0.01% 1357
2016
Q1
$1.7M Sell
28,050
-3,538
-11% -$208K ﹤0.01% 1496
2015
Q4
$2.02M Buy
31,588
+24,366
+337% +$1.58M ﹤0.01% 1406
2015
Q3
$484K Sell
7,222
-622
-8% -$44K ﹤0.01% 2214
2015
Q2
$536K Buy
7,844
+228
+3% +$14.5K ﹤0.01% 2131
2015
Q1
$423K Buy
7,616
+1,128
+17% +$57.8K ﹤0.01% 2201
2014
Q4
$333K Sell
6,488
-20,684
-76% -$1.02M ﹤0.01% 2289
2014
Q3
$1M Sell
27,172
-63,028
-70% -$2.27M ﹤0.01% 1439
2014
Q2
$3.52M Sell
90,200
-7,622
-8% -$283K ﹤0.01% 1046
2014
Q1
$3.69M Buy
97,822
+1,346
+1% +$47K ﹤0.01% 1033
2013
Q4
$3.65M Buy
96,476
+2,452
+3% +$93.8K ﹤0.01% 1046
2013
Q3
$4.08M Buy
94,024
+86,650
+1,175% +$3.48M ﹤0.01% 1011
2013
Q2
$267K Buy
+7,374
New +$224K ﹤0.01% 2286

Other funds holding USNA

BlackRock Advisors's USNA Position: Q4 2016 in Review

BlackRock Advisors increased its Usana Health Sciences (USNA) stake by 4.2% in Q4 2016, buying an estimated $14.7K and bringing the position to 5,576 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #2437.

BlackRock Advisors first reported a position in USNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.08M in Q3 2013. 149 funds tracked by Wall St. Rank hold USNA as of Q4 2016.

  • BlackRock Advisors held 5,576 shares of Usana Health Sciences worth $341K as of Q4 2016.
  • BlackRock Advisors bought 226 Usana Health Sciences shares in Q4 2016, an estimated $14.7K.
  • Usana Health Sciences made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2437 holding.
  • BlackRock Advisors first reported a position in Usana Health Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Usana Health Sciences position peaked at $4.08M in Q3 2013.
  • 149 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.